Delivery Order SPE2DB20D2002-SPE2DB26FK96X
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,627.61 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mesalamine 800 mg delayed-release tablets in a quantity of 180 units. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) at a ceiling value of $1,559.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by October 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) with a contract ceiling value of $2,854.12. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, representing a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The award carries no set-aside designation, indicating it was competitively awarded to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine 800 mg delayed-release tablets (180-count quantity) under a firm fixed-price contract valued at $1,520.96. The award, issued on June 27, 2025, is a non-set-aside competitive delivery order with an ultimate completion date of June 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply delivery. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120-count supply) on September 18, 2025, with a ceiling value of $8,208.17 and an ultimate completion date of September 19, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.12 to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180 count) with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $6,571.87 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count supply) with a completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120 count) on August 29, 2025, with a ceiling value of $1,419.34 and completion deadline of September 2, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $3,721.27. This is a firm fixed-price delivery order with an ultimate completion date of April 24, 2025, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $16,681.52 to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180-count units). This firm fixed-price delivery order, issued on August 1, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB26FK96XDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Mesalamine 800 mg delayed-release tablets (180-count units) under a firm fixed-price contract valued at $2,968.38. This non-set-aside, competitively awarded delivery order is scheduled for completion by October 16, 2025, with performance at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. The prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency and military healthcare requirements globally. The Mesalamine order supports federal healthcare procurement needs through the Defense Logistics Agency's established pharmaceutical supply chain, consistent with AmerisourceBergen's demonstrated capability to fulfill diverse medical product requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/15/25 |